Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients (Q40214692)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 March 2014
edit
Language Label Description Also known as
English
Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients
scientific article published on 13 March 2014

    Statements

    Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit